“So you’re saying there was no blood reaction found anywhere in the entire lab building?”
Eliza frowned. Something about it didn’t sit right.
If there were no traces of blood in the building, then where exactly had Nina been dismembered? There couldn’t be no trace at all.
Nolan said, “There’s only one possibility
someone must have used chemical agents to clean up every
drop of blood, and done it so thoroughly that no reaction could be detected.”
Pulling that off would have required a massive cleanup.
According to the earlier security footage, Emilia had gone in and come out just an hour later. Cleaning a dismemberment scene in under an hour was practically impossible.
That meant the killer wasn’t Emilia at least, she wasn’t the one who cleaned up afterward.
Realizing this, Eliza said, “Then it’s very likely she was being–framed. Whoever did it took advantage of Emilia showing up by chance, maybe even because she saw something – – so they made her the scapegoat.”
“It’s possible,” Nolan agreed.
Hearing that both of them believed Emilia hadn’t killed anyone, Jean grew excited. “Ms. Eliza, then can this be counted as evidence to clear her name?”
“This can only be considered a point of doubt, not actual evidence,” Eliza said, shaking her head. “I have another question for you.”
“Go ahead.”
–
“This experiment she was supposed to take part in
–
what exactly was it about?”
—
“She told me before it was a study on a new drug related to the flu outbreak from earlier. At the time, our medical school had a lot of graduate students working on the development of new medication. Even though the flu has now become common and the virus is weaker, it’s still unstable. I don’t have clearance to see the full research, but she and Nina were definitely doing reports on it.”
“So Nina, who was just as outstanding academically, also wanted in on this new–drug research- and the experiment’s content was exactly that?”
Jean nodded. That was indeed the case.
Hearing this, Eliza seemed to have found a key point. “Next time we visit the lab, we may need to trouble- you again.”
“No problem – just call me whenever you need me.” Jean only wanted to clear Emilia’s name as soon as possible.
Eliza turned to Nolan. “Let’s go.”
“Alright.”
The three of them left the lab building quickly.
Chapter 484 No Trace of Blood
Since there were no internal surveillance cameras, unless someone deliberately went looking through footage from nearby areas, no one would know they’d been there that night.
Back home, Eliza took out the vial of medicine Nolan had prepared for her earlier.
There was no packaging, but on the back was a raised imprint Foster Group Pharmaceuticals.
The moment she saw it came from Foster Group, she wasn’t surprised.
The Foster family had long been investors in Claire University’s medical school, pouring in money for years. Every student who graduated from there went on to work at the central city hospital way of cultivating talent.
Even the newest drugs were funded and developed by Foster Group.
a disguised
If Ethan hadn’t killed himself, both he and Emilia would probably have worked at the central hospital, with excellent pay and benefits.
Eliza said, “Should we stir things up a bit and throw them into chaos?”
“Sure,” Nolan replied immediately, already knowing what she meant.
The very next morning, an anonymous news post appeared online.
It claimed that Foster Group had developed a new drug ahead of time – specifically targeting the recent flu outbreak.
The report vividly described how Foster Group had supposedly exploited the virus to spread it, then profited from the outbreak through their medication.
The news set the internet ablaze.
People began to suspect it was true – after all, how else could Foster Group have known an outbreak was coming and developed a treatment in advance?
Soon, online discussions turned into public outrage, demanding to know what was going on.
Some even ran their own analysis, estimating just how much money Foster Group had made off the
outbreak.
The results were staggering – the once–declining company had raked in enormous profits.
726
1
